article

Screening In-Depth Focus 2017

Posted: 5 June 2017 | | No comments yet

Included in this Screening In-Depth Focus: Phenotypic and target-based screening; Killing cancer cells using clinical drug resistance; Inflammatory biomarkers as a herbal anti-arthritic drug discovery tool…

Screening in-depth focus digital issue #2 2017
  • Phenotypic and target-based screening – complementary or competing?
    Sheraz Gul, Fraunhofer-IME SP
  • Using clinical drug resistance to kill cancer cells
    Howard Fearnhead, NUI Galway and Sheraz Gul, Fraunhofer-IME SP
  • Inflammatory biomarkers as a herbal anti-arthritic drug discovery tool
    Mahfoozur Rahman, Sam Higginbottom University of Agriculture, Technology & Sciences; Sarwar Beg, University Institute of Pharmaceutical Sciences; Imran Kazmi, Glocal School of Pharmacy; Amita Verma, Shalom Institute of Health and Allied sciences; Firoz Anwar, King Abdulaziz University; Vikas Kumar, Shalom Institute of Health and Allied sciences

This Screening In-Depth Focus is restricted - login or subscribe free to access

Screening the future innovations in drug discoveryThank you for visiting our website. To access this content in full you'll need to login. It's completely free to subscribe, and in less than a minute you can continue reading. If you've already subscribed, great - just login.

Why subscribe? Join our growing community of thousands of industry professionals and gain access to:

  • quarterly issues in print and/or digital format
  • case studies, whitepapers, webinars and industry-leading content
  • breaking news and features
  • our extensive online archive of thousands of articles and years of past issues
  • ...And it's all free!

Click here to Subscribe today Login here

 


Leave a Reply

Your email address will not be published. Required fields are marked *